Cel Sci Corporation (CVM)

[meirluc]

Zhiyuan Sun's article is totally misleading in that he gives the Multikine trial an equal chance of success or failure (50/50) and is estimating that the multikine treated population will equal anywhere between -10% to
+10% of the number of fatalities of the SOC arm.

Well that is not a 50% chance of success because we all know is that for success, the Multikine treated arm must have at least 10% fewer events than SOC (-10%) and Mr. Sun's range of -10% to +10% therefore gives us hardly any room for success.

His argument that if the results had been spectacular, Cel Sci should have for ethical reasons released the results is nonsensical because the superiority of the Multikine arm may not be expressed maximally until after the first three years on trial (just a speculation) or there may be other reasons for waiting until the 298th event.